Meeting abstract

Golimumab (Simponi™) - prvi supkutani anti-TNF-α koji se primjenjuje jedanput mjesečno

Branimir Anić ; Department for Clinical Immunology and Rheumatology, Clinic for Internal Medicine, Clinical Hospital Centre Zagreb, Zagreb, Croatia
Đurđica Babić-Naglić ; Clinic for Rheumatic Diseases and Rehabilitation, Clinical Hospital Centre Zagreb, Zagreb, Croatia
Nada Čikeš ; Department for Clinical Immunology and Rheumatology, Clinic for Internal Medicine, Clinical Hospital Centre Zagreb, Zagreb, Croatia
Božidar Ćurković ; Clinic for Rheumatic Diseases and Rehabilitation, Clinical Hospital Centre Zagreb, Zagreb, Croatia
Marija Glasnović ; Clinical Department for Rheumatology and Clinical Immunology, Clinic for Internal Medicine, Clinical Hospital Centre Osijek, Osijek, Croatia
Simeon Grazio ; Clinic for Rheumatology, Physical Medicine and Rehabilitation, Clinical Hospital Centre “Sestre milosrdnice”, Zagreb, Croatia
Tatjana Kehler ; Thalassotherapia Opatija – Special Hospital for Rehabilitation of Heart and Lung Diseases and Rheumatism, Opatija, Croatia
Dušanka Martinović Kaliterna ; Department for Clinical Immunology and Rheumatology, Clinic for Internal Medicine, Clinical Hospital Centre Split, Split, Croatia
Jadranka Morović-Vergles ; Department for Clinical Immunology and Rheumatology, Clinic for Internal Medicine, Clinical Hospital “Dubrava”, Zagreb, Croatia
Srđan Novak ; Department for Rheumatology and Clinical Immunology, Clinic for Internal Medicine, Clinical Hospital Centre Rijeka, Rijeka, Croatia
Tonko Vlak ; Department for Physical Medicine, Rehabilitation and Rheumatology, Clinical Hospital Centre Split, Split, Croatia

Abstract

Keywords

golimumab; novi supkutani anti-TNF-α; reumatoidni artritis; psorijatični artritis; ankilozantni spondilitis

Hrčak ID:

124472

URI

https://hrcak.srce.hr/124472

Publication date:

20.10.2011.

Article data in other languages: english

Visits: 1.248 *